Tyra Biosciences, Inc. ( TYRA) - Key Metrics
TYRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.69 | -$0.47 | -$0.47 |
| 2026Q1 | $0 | -$0.64 | -$0.53 | -$0.53 |
| 2025Q4 | $0 | -$0.57 | -$0.40 | -$0.40 |
| 2025Q3 | $0 | -$0.50 | -$0.38 | -$0.38 |
| 2025Q2 | $0 | -$0.47 | -$0.40 | -$0.40 |
TYRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -11.57 |
| 2026Q1 | 0% | -14.96 |
| 2025Q4 | 0% | -11.53 |
| 2025Q3 | 0% | -7.00 |
| 2025Q2 | 0% | -5.09 |
TYRA
Price: $26.22
52 week price:
Earnings Per Share: -2.42 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1674
Market Capitalization: 1.5 billion